Ryan Frazer
Physician Assistant · Phoenix, AZNPI 1720457351
Payments from drug & device makers
Across 311 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Viiv Healthcare Company$2K
- Johnson & Johnson$507
- Merck$333
- AbbVie$264
- Janssen Products, LP$184
- plus $765 from 16 others
What the payments were for
- Speaking & faculty fees$180%
- Food & beverage$5,82997%
- Education$1843%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 131 | $2,422 |
| Viiv Healthcare Company | 77 | $1,556 |
| Johnson & Johnson | 34 | $507 |
| Merck | 16 | $333 |
| AbbVie | 12 | $264 |
| Janssen Products, LP | 2 | $184 |
| Novo Nordisk | 7 | $118 |
| Abbott | 6 | $111 |
| Napo Pharmaceuticals Inc | 5 | $85 |
| Lucid Diagnostics Inc. | 2 | $75 |
| Novartis | 2 | $47 |
| Hologic Sales And Service, LLC | 1 | $42 |
| Medtronic | 3 | $41 |
| Indivior Inc. | 1 | $38 |
| Boehringer Ingelheim | 2 | $37 |
| Exact Sciences | 2 | $32 |
| Antares Pharma, Inc. | 2 | $31 |
| EMD Serono, Inc. | 2 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Nalu Medical, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Halozyme Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yeztugo$126
How this compares
$6,031 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DovatoDolutegravir Sodium/Lamivudine | 11 | $37,604 |
| DescovyEmtricitabine/Tenofov Alafenam | 13 | $32,853 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato | $1,556 | $37,60411 claims |
| GileadDescovy | $2,422 | $32,85313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Phoenix
- Alyssa BoschenPhoenix$86K
- Katherine MinorPhoenix$76K
- Micah LasleyPhoenix$52K
- Thomas SirrinePhoenix$37K
- Karla HortonPhoenix$36K
- Larissa AnthonyPhoenix$32K
- Tana FrumentoPhoenix$25K
- Rosemary SrisukPhoenix$17K
- John DorseyPhoenix$17K
- Kendall SmithPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.